These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 20162169)
1. Synthesis of AZT-based cationic lipids and in vitro evaluation of siRNA delivery. Park SM; Woo J; Jeon E; Kim BH Chem Commun (Camb); 2010 Mar; 46(9):1523-5. PubMed ID: 20162169 [TBL] [Abstract][Full Text] [Related]
2. Anionic amino acid-derived cationic lipid for siRNA delivery. Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256 [TBL] [Abstract][Full Text] [Related]
3. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Zhu C; Jung S; Luo S; Meng F; Zhu X; Park TG; Zhong Z Biomaterials; 2010 Mar; 31(8):2408-16. PubMed ID: 19963269 [TBL] [Abstract][Full Text] [Related]
4. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Spagnou S; Miller AD; Keller M Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141 [TBL] [Abstract][Full Text] [Related]
5. Short interfering RNA-mediated gene silencing of vascular endothelial growth factor: effects on cellular proliferation in colon cancer cells. Mulkeen AL; Silva T; Yoo PS; Schmitz JC; Uchio E; Chu E; Cha C Arch Surg; 2006 Apr; 141(4):367-74; discussion 374. PubMed ID: 16618894 [TBL] [Abstract][Full Text] [Related]
6. Cationic lipids and polymers mediated vectors for delivery of siRNA. Zhang S; Zhao B; Jiang H; Wang B; Ma B J Control Release; 2007 Oct; 123(1):1-10. PubMed ID: 17716771 [TBL] [Abstract][Full Text] [Related]
8. Efficient intracellular siRNA delivery strategy through rapid and simple two steps mixing involving noncovalent post-PEGylation. Kong WH; Sung DK; Shim YH; Bae KH; Dubois P; Park TG; Kim JH; Seo SW J Control Release; 2009 Sep; 138(2):141-7. PubMed ID: 19426771 [TBL] [Abstract][Full Text] [Related]
9. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach. Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451 [TBL] [Abstract][Full Text] [Related]
10. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide. Lee SH; Kim SH; Park TG Biochem Biophys Res Commun; 2007 Jun; 357(2):511-6. PubMed ID: 17434451 [TBL] [Abstract][Full Text] [Related]
11. Delivery of small interfering RNA to mammalian cells in culture by using cationic lipid/polymer-based transfection reagents. Brazas RM; Hagstrom JE Methods Enzymol; 2005; 392():112-24. PubMed ID: 15644178 [TBL] [Abstract][Full Text] [Related]
12. Cationic nucleolipids as efficient siRNA carriers. Yang HW; Yi JW; Bang EK; Jeon EM; Kim BH Org Biomol Chem; 2011 Jan; 9(1):291-6. PubMed ID: 21082158 [TBL] [Abstract][Full Text] [Related]
13. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug. Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631 [TBL] [Abstract][Full Text] [Related]
14. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Kim WJ; Christensen LV; Jo S; Yockman JW; Jeong JH; Kim YH; Kim SW Mol Ther; 2006 Sep; 14(3):343-50. PubMed ID: 16765648 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery. Lee DW; Yun KS; Ban HS; Choe W; Lee SK; Lee KY J Control Release; 2009 Oct; 139(2):146-52. PubMed ID: 19567259 [TBL] [Abstract][Full Text] [Related]
16. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo. He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713 [TBL] [Abstract][Full Text] [Related]
17. Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome. Watanabe T; Umehara T; Yasui F; Nakagawa S; Yano J; Ohgi T; Sonoke S; Satoh K; Inoue K; Yoshiba M; Kohara M J Hepatol; 2007 Dec; 47(6):744-50. PubMed ID: 17822798 [TBL] [Abstract][Full Text] [Related]
18. Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation. Barichello JM; Ishida T; Kiwada H Methods Mol Biol; 2010; 605():461-72. PubMed ID: 20072901 [TBL] [Abstract][Full Text] [Related]
19. A peptidomimetic siRNA transfection reagent for highly effective gene silencing. Utku Y; Dehan E; Ouerfelli O; Piano F; Zuckermann RN; Pagano M; Kirshenbaum K Mol Biosyst; 2006 Jun; 2(6-7):312-7. PubMed ID: 16880950 [TBL] [Abstract][Full Text] [Related]
20. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference. Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]